REG - Clontarf Energy PLC - Lithium Prospecting in Bolivia

Clontarf EnergyAnnouncement

20/09/2018 10:05

RNS Number : 3977B
Clontarf Energy PLC
20 September 2018
 


 
 
 
 
20th September 2018
 
 
Clontarf Energy plc
("Clontarf" or "the Company")
 
 
Lithium Prospecting in Bolivia
  
Clontarf Energy, the oil and gas exploration company, is pleased to announce that it has submitted a proposal to explore one the world's largest Lithium-bearing salt-lakes in Bolivia.  Lithium from salt pans is in demand for high performance batteries.
 
David Horgan, Director, commented:
 
"We have re-established our presence in Bolivia, and have initiated discussions with the Bolivian National Lithium Company (YLB) on a possible joint venture to study and, if indicated, explore the second largest lithium brine deposit in the world.  Between 2008 and 2010 Clontarf examined salt pan lithium deposits in Bolivia but we were unable to proceed at that time.  Lithium from salt pans is in demand for high performance batteries."
 
There is no guarantee that this work will lead to a binding contract.
 
This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
 
 
 
ENDS
 
For further information please visit http://www.clontarfenergy.com/ or contact:
 
 Enquiries:
 



Clontarf Energy








John Teeling, Chairman


+353 (0) 1 833 2833




David Horgan, Director


















Nominated Adviser and Broker








Northland Capital Partners Limited








Tom Price and Dugald Carlean
 (Corporate Finance)


+44 (0) 20 3861 6625




Rob Rees / Isabella Pierre
 


















Public Relations








Blytheweigh


+44 (0) 207 138 3206




Simon Woods


+44 (0) 746 643 9633




Camilla Horsfall


+44 (0) 787 184 1793














 
Teneo PSG








Luke Hogg


+353 (0) 1 661 4055




Alan Tyrrell


+353 (0) 1 661 4055



 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAPNEASPPEEF